To study about axillary block using 0.5% ropivacaine in arm and forearm surgeries

Comparison between the efficacy of dexmedetomidine versus magnesium sulphate as adjuvants to 0.5 percent ropivacaine in axillary brachial plexus block in hand and forearm surgeries - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091316

Enrollment

Registered

2025-07-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: Dexmedetomidine: Use of dexmedetomidine in 27PATIENTS 24ml of 0.5%ropivacaine + 0.5 mcg/kg dexmedetomidine (diluted with 0.9 % normal saline to 1 ml) in prolonging the duration of axi

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II patients Aged between 18-60 years of either sex. Patients undergoing hand and forearm surgery. Availability of informed consent.

Exclusion criteria

Exclusion criteria: Patients with ASA physical status III or more. Patients with below 18 years and above 60 years. Patients posted for emergency procedures. Patients with major neurological, cardiac, respiratory, metabolic, renal, hepatic disease or with coagulation abnormalities. Patients contraindicated for regional technique. Patients with known allergies to the local anaesthetics

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of dexmedetomidine versus magnesium sulphate as adjuvants to 0.5% ropivacaine in axillary brachial plexus block in hand and forearm surgeriesTimepoint: The effects of the block needs to be assessed at baseline, after drug administration, after 5,10,15,30,45,60,90,120,150,180 minutes and at the end of surgery	—

Secondary

Measure	Time frame
To compare the efficacy of dexmedetomidine versus magnesium sulphate as adjuvants to 0.5% ropivacaine in axillary brachial plexus block in hand & forearm surgeries on the basis of duration of block, bromage scale, VAS score & requirement of any postop analgesiaTimepoint: To assess the duration of analgesia post surgery with the help of VAS score system every 2 hourly till 24 hours post surgery	—

Countries

India

Contacts

Public ContactDr shilpa Kore

Dr D.Y. Patil Medical college and hospital and Research center

shilpasale@gmail.com9767002436

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026